Fasnall, a thiophenopyrimidine, is a selective fatty acid synthase (FASN) inhibitor that shows potent anti-tumor activity.
Fasnall and IU1 have different modes of metabolic variability in cancer cells.[2]
[1] Yazan Alwarawrah, et al. Cell Chem Biol. 2016 Jun 23;23(6):678-88. [2] Yang JS, et al. Int J Mol Sci. 2021 Dec 14;22(24):13437.
















